CVS to pay $315M to settle US opioid prescription lawsuit

CVS Health agreed to pay $315 million to resolve US DOJ allegations that it filled opioid prescriptions without clinical justification. This settlement is part of a broader pattern of opioid-related litigation against pharmacy chains, but marks a notable corporate financial penalty. The deal removes legal uncertainty for CVS but does not resolve all opioid-related claims.